Remove Engineering Remove Hospital Remove Provider Remove Treatment Plan
article thumbnail

New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects

Medical Xpress

Researchers from the Wellcome Sanger Institute, the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust (CUH) and their collaborators analyzed blood cell genomes from 23 patients of all ages who had been treated with a range of chemotherapies. The content is provided for information purposes only.

Patients 101